Xencor

Xencor

Xencor

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.
Founded
1997
Raised
$15M
Follow us
Also headquartered in Monrovia
Alexa global traffic share